SCHEMBL30615580

SCHEMBL30615580

CNC(=O)c1ccc(-n2c(=O)[nH]c3ccccc32)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ APEX1 P27695 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ THPO P40225 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ PMP22 Q01453 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ AURKA O14965 3/20 0.46
▸ TNKS O95271 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21463825 1.00 MAPT (0.49) MAPTKDM4ENPC1ALDH1A1LMNA
SCHEMBL30615322 0.85 ADORA3 (0.52) MAPTKDM4ENPC1ALDH1A1LMNA
SCHEMBL28488324 0.85 ADORA3 (0.52) MAPTKDM4ENPC1ALDH1A1LMNA
SCHEMBL28488054 0.85 KCNMA1 (0.47) MAPTKDM4ENPC1ALDH1A1LMNA
SCHEMBL30615677 0.84 DAO (0.44) MAPTAURKAPARP1PARP2PARP6
SCHEMBL21464136 0.84 DAO (0.44) MAPTKDM4ENPC1ALDH1A1LMNA
SCHEMBL28495301 0.84 DAO (0.44) MAPTAURKAPARP1PARP2PARP6
SCHEMBL21463397 0.83 LMNA (0.49) MAPTKDM4ENPC1ALDH1A1LMNA
SCHEMBL21463493 0.83 LMNA (0.49) MAPTKDM4ENPC1ALDH1A1LMNA
SCHEMBL30615554 0.83 LMNA (0.49) MAPTKDM4ENPC1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868037-B Fused cyclic urea derivatives as CRHR2 antagonists 拉夸里亚创药株式会社 2023-10-13 — — CN disclosed
Send feedback